rs77716946

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000093.5(COL5A1):​c.1936-21G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0342 in 1,612,444 control chromosomes in the GnomAD database, including 1,094 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 84 hom., cov: 33)
Exomes 𝑓: 0.035 ( 1010 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.47

Publications

4 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 9-134761904-G-A is Benign according to our data. Variant chr9-134761904-G-A is described in ClinVar as Benign. ClinVar VariationId is 255058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0273 (4161/152326) while in subpopulation NFE AF = 0.0393 (2675/68030). AF 95% confidence interval is 0.0381. There are 84 homozygotes in GnomAd4. There are 2045 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 4161 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.1936-21G>A intron_variant Intron 18 of 65 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.1936-21G>A intron_variant Intron 18 of 65 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.1936-21G>A intron_variant Intron 18 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.1936-21G>A intron_variant Intron 18 of 65 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.1936-21G>A intron_variant Intron 18 of 65 2 ENSP00000360885.4 P20908-2H7BY82

Frequencies

GnomAD3 genomes
AF:
0.0274
AC:
4163
AN:
152208
Hom.:
84
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00615
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0224
Gnomad ASJ
AF:
0.0446
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0164
Gnomad FIN
AF:
0.0526
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0393
Gnomad OTH
AF:
0.0339
GnomAD2 exomes
AF:
0.0300
AC:
7534
AN:
250822
AF XY:
0.0305
show subpopulations
Gnomad AFR exome
AF:
0.00580
Gnomad AMR exome
AF:
0.0185
Gnomad ASJ exome
AF:
0.0361
Gnomad EAS exome
AF:
0.000653
Gnomad FIN exome
AF:
0.0497
Gnomad NFE exome
AF:
0.0407
Gnomad OTH exome
AF:
0.0332
GnomAD4 exome
AF:
0.0349
AC:
51015
AN:
1460118
Hom.:
1010
Cov.:
31
AF XY:
0.0346
AC XY:
25161
AN XY:
726420
show subpopulations
African (AFR)
AF:
0.00487
AC:
163
AN:
33474
American (AMR)
AF:
0.0195
AC:
871
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0378
AC:
986
AN:
26106
East Asian (EAS)
AF:
0.000554
AC:
22
AN:
39692
South Asian (SAS)
AF:
0.0168
AC:
1446
AN:
86240
European-Finnish (FIN)
AF:
0.0477
AC:
2517
AN:
52766
Middle Eastern (MID)
AF:
0.0304
AC:
175
AN:
5764
European-Non Finnish (NFE)
AF:
0.0386
AC:
42885
AN:
1111018
Other (OTH)
AF:
0.0323
AC:
1950
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
2349
4699
7048
9398
11747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1566
3132
4698
6264
7830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0273
AC:
4161
AN:
152326
Hom.:
84
Cov.:
33
AF XY:
0.0275
AC XY:
2045
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00614
AC:
255
AN:
41564
American (AMR)
AF:
0.0225
AC:
344
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0446
AC:
155
AN:
3472
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5192
South Asian (SAS)
AF:
0.0164
AC:
79
AN:
4824
European-Finnish (FIN)
AF:
0.0526
AC:
559
AN:
10618
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0393
AC:
2675
AN:
68030
Other (OTH)
AF:
0.0336
AC:
71
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
214
428
643
857
1071
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0257
Hom.:
25
Bravo
AF:
0.0248

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Ehlers-Danlos syndrome, classic type Benign:1
Jul 31, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.011
DANN
Benign
0.62
PhyloP100
-1.5
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77716946; hg19: chr9-137653750; COSMIC: COSV107479198; API